This inventor holds 1 USPTO granted patent. Top assignee: Novartis Pharma Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lu Huang: Innovator in Chimeric Antigen Receptor Technology
Introduction
Lu Huang is an accomplished inventor based in West Roxbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptor (CAR) technology. His innovative work has the potential to revolutionize cancer treatment and immunotherapy.
Latest Patents
Lu Huang holds a patent for "Methods of Making Chimeric Antigen Receptor-Expressing Cells." This patent represents a crucial advancement in the creation of cells that can effectively target and destroy cancer cells. His work in this area is vital for the ongoing development of CAR T-cell therapies.
Career Highlights
Lu Huang is currently employed at Novartis Pharma AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His dedication to innovation has positioned him as a key player in the biotechnology sector.
Collaborations
Lu Huang has worked alongside notable colleagues, including Louise Mary Treanor and Michael R. Greene. These collaborations have fostered a dynamic research environment, enabling the exchange of ideas and expertise that drive advancements in their shared field.
Conclusion
Lu Huang's contributions to the field of chimeric antigen receptor technology exemplify the impact of innovative thinking in biotechnology. His patent and work at Novartis Pharma AG highlight his commitment to improving cancer treatment through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile